AVE 33.3% 0.2¢ avecho biotechnology limited

Why are you still in POH?, page-3

  1. 642 Posts.
    lightbulb Created with Sketch. 63
    FWIW...

    I think most current holders would feel trapped to some extent or at least a bit anxious/vulnerable because selling now would realize a substantial loss which is difficult for both the wallet and the ego to handle.

    People buy on the belief that based on their entry price the SP will go higher over a particular time frame...nobody buys because they believe that the share price will go lower.

    This may be denial on my behalf, however I think the chances of developing a commercial outcome from BOTH pain patches, (OxcyM - systemic and OxcyC - topical), is still a reasonable probability even though this is going to take time and there is still risk attached.

    Personally I accept that risk, however the unfolding of this technology is out of my control so the issue is more about managing risk and my tolerance for risk.

    So in essence, if my analysis, point of view, or best guess is correct I will do well over time but it would be far easier to hold that conviction if the SP was presently higher than my current average cost price.

    I understand if others have a different point of view, whatever your point of view is it is correct for you...so it's not for me to try to change anyone's perspective, each person must decide for themselves.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.